Interleukin-31 Receptor alpha Antagonist [EPC]

15930 reported adverse events

Drugs of this class: NEMOLIZUMAB-ILTO

These side effects are most commonly reported by patients taking drugs of the Interleukin-31 Receptor alpha Antagonist [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 5792
1 DEVICE MALFUNCTION 2529
2 PRURITUS 1581
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1578
4 INCORRECT DOSE ADMINISTERED 1544
5 RASH 1056
6 DRUG INEFFECTIVE 947
7 DEVICE USE ERROR 658
8 DERMATITIS ATOPIC 556
9 HEADACHE 505
See all common reactions for Interleukin-31 Receptor alpha Antagonist [EPC]

Drugs of the Interleukin-31 Receptor alpha Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEURODERMATITIS 306 0.0821
1 ECZEMA WEEPING 8 0.0611
2 ECZEMA NUMMULAR 25 0.0511
3 DEVICE MALFUNCTION 2529 0.0360
4 SKIN WEEPING 98 0.0274
5 SKIN DISCHARGE 9 0.0236
6 PRODUCT DOSE OMISSION ISSUE 5792 0.0197
7 DEVICE USE ERROR 658 0.0189
8 SKIN TEXTURE ABNORMAL 15 0.0157
9 DEVICE USE ISSUE 269 0.0154
See all enriched reactions for Interleukin-31 Receptor alpha Antagonist [EPC]